MedTrace Logo

Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer

NCT01305967 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-03-01

No results posted yet for this study

Summary

The purpose of this study is to determine efficacy of SB injection in Non Small Cell Lung Cancer.

Conditions

  • Non Small Cell Lung Cancer

Interventions

DRUG

SB injection

Infusion SBinjection of 21.87ml/m\^2, Intravenous route, 16times for 2.5 months

Sponsors & Collaborators

  • SBPharmaceutical IND, Co., LTD

    lead INDUSTRY

Principal Investigators

  • Jae-yong Park, Professor · Kyungpook University Hospital

  • Seung-beom Han, Professor · Keimyung University Dongsan Medical Center

  • Chae-young Lee, Medical Doctor · Anyang Sam Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2011-05-31
Completion
2011-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01305967 on ClinicalTrials.gov